These findings contrast with Hashimoto’s result that21 no differences were observed for serum levels of EGF in drug naïve, first-episode (n = 15) and chronically medicated patients (n = 25) with schizophrenia versus general population controls. The gene discussed is EGF; the disease is schizophrenia.